Galmed Pharmaceuticals Overview

Galmed Pharmaceuticals Operating Income

Operating Income for GLMD.

Quarterly Operating Income

$-3042000.00

↑ 94.38% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$-8510000.00

↑ 103.2% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin